Wakol Sealing Compounds

for Aerosol

Método de aplicação

  • Suitable for slow-to high-speed liners

  • Suitable for common lining systems

Filling/Packaging

  • General line and food

  • Excellent pressure resistance

Advantages

  • Excellent chemical resistance including hairspray

  • Long term market experience

  • Suitable for all common propellants

Additional Information

  • Approved for food contact

Pre-vulcanised products

Pre-vulcanised products

Special Advantages

  • Insensitive to process conditions

  • Longer shelf-life

Special Advantages

  • Suitable for slow- to mediumspeed liners

  • Good shear stability

  • Good adhesion on all common lacquers

  • Suitable for pasteurization

  • Suitable for all common feeding systems

  • Long time experience with a lot of filling goods

  • Good chemical resistance

Properties Range

  • Solid content: 40-67%

  • Viscosity (WPV 74): 100-330 mPas

  • Density dry: 1,53-1,60 g/cm³

  • Density wet: 1,29-1,33 g/cm³

  • Colour: grey, red, dark red

Additional Information

  • Certificate available

  • Regulation (EC) 1935/2004/EG

  • FDA 21 CFR 175.300


Vulcanising products

Vulcanising products

Special Advantages

  • Excellent chemical resistance

  • Higher modulus

Special Advantages

  • Suitable for slow-to-high-speed liners

  • Good adhesion on all common lacquers

  • Suitable for common feeding systems

  • Improved shear stability

  • Low sedimentation tendency

Properties Range

  • Solid content: 65-68%

  • Viscosity (WPV 74): 200-450 mPas

  • Density dry: 1,52 g/cm³

  • Density wet: 1,30 g/cm³

  • Colour: grey, red

Additional Information

  • Certificate available

  • Regulation (EC) 1935/2004/EG

  • FDA 21 CFR 175.300


Special Advantages

  • Suitable for medium-to highspeed liners

Properties Range

  • Solid content: 68-73%

  • Viscosity (WPV 74): 340-450 mPas

  • Density dry: 1,52-158 g/cm³

  • Density wet: 1,30-1,37 g/cm³

  • Colour: red

Additional Information

  • Certificate available

  • Regulation (EC) 1935/2004/EG

  • FDA 21 CFR 175.300